Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Knowing when to start retirement planning is crucial for a secure future. Gain insights that will help you prepare effectively for retirement.
15,993 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
As Rocket Lab nears a pivotal earnings print, investors are quietly growing more bullish. This piece breaks down why ...
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
Tampa International Airport posted a pajama ban joke on social media, quickly going viral before officials clarified ...
Geopolitical strain near Iran is intensifying, with potential ripple effects on oil prices and household budgets. Ana...
'scream 7' opened with a $64.1 million domestic debut, the year’s best start and a clear sign that millennial nostalg...
A new Vehicle Dependability Study ranks america’s worst brand last among major automakers, highlighting rising repair...
Capital moves matter. Capricorn Investment Group reduced its Navitas Semiconductor stake by about 1.19 million shares...
GitLab delivered solid revenue growth but offered modest profitability guidance, triggering a sharp stock move. This ...
eXp Realty unveils a new division to help agents break into the new construction market. The program aims to close th...